Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1991 Oct 5;303(6806):800–801. doi: 10.1136/bmj.303.6806.800

Verocytotoxin producing Escherichia coli.

M G Brook, B A Bannister
PMCID: PMC1671176  PMID: 1932966

Full text

PDF
800

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bryant H. E., Athar M. A., Pai C. H. Risk factors for Escherichia coli O157:H7 infection in an urban community. J Infect Dis. 1989 Nov;160(5):858–864. doi: 10.1093/infdis/160.5.858. [DOI] [PubMed] [Google Scholar]
  2. Carter A. O., Borczyk A. A., Carlson J. A., Harvey B., Hockin J. C., Karmali M. A., Krishnan C., Korn D. A., Lior H. A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home. N Engl J Med. 1987 Dec 10;317(24):1496–1500. doi: 10.1056/NEJM198712103172403. [DOI] [PubMed] [Google Scholar]
  3. Chart H., Smith H. R., Scotland S. M., Rowe B., Milford D. V., Taylor C. M. Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet. 1991 Jan 19;337(8734):138–140. doi: 10.1016/0140-6736(91)90801-u. [DOI] [PubMed] [Google Scholar]
  4. Cimolai N., Carter J. E., Morrison B. J., Anderson J. D. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr. 1990 Apr;116(4):589–592. doi: 10.1016/s0022-3476(05)81609-9. [DOI] [PubMed] [Google Scholar]
  5. Cooke E. M. Epidemiology of foodborne illness: UK. Lancet. 1990 Sep 29;336(8718):790–793. doi: 10.1016/0140-6736(90)93251-j. [DOI] [PubMed] [Google Scholar]
  6. Defreyn G., Proesmans W., Machin S. J., Lemmens F., Vermylen J. Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions. Clin Nephrol. 1982 Jul;18(1):43–49. [PubMed] [Google Scholar]
  7. Edelman R., Karmali M. A., Fleming P. A. From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. J Infect Dis. 1988 May;157(5):1102–1104. doi: 10.1093/infdis/157.5.1102. [DOI] [PubMed] [Google Scholar]
  8. Griffin P. M., Olmstead L. C., Petras R. E. Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases. Gastroenterology. 1990 Jul;99(1):142–149. doi: 10.1016/0016-5085(90)91241-w. [DOI] [PubMed] [Google Scholar]
  9. Johnson W. M., Lior H., Bezanson G. S. Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada. Lancet. 1983 Jan 1;1(8314-5):76–76. doi: 10.1016/s0140-6736(83)91616-1. [DOI] [PubMed] [Google Scholar]
  10. Karmali M. A. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev. 1989 Jan;2(1):15–38. doi: 10.1128/cmr.2.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karmali M. A., Steele B. T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983 Mar 19;1(8325):619–620. doi: 10.1016/s0140-6736(83)91795-6. [DOI] [PubMed] [Google Scholar]
  12. Kleanthous H., Smith H. R., Scotland S. M., Gross R. J., Rowe B., Taylor C. M., Milford D. V. Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects. Arch Dis Child. 1990 Jul;65(7):722–727. doi: 10.1136/adc.65.7.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. March S. B., Ratnam S. Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol. 1986 May;23(5):869–872. doi: 10.1128/jcm.23.5.869-872.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marshall W. F., McLimans C. A., Yu P. K., Allerberger F. J., Van Scoy R. E., Anhalt J. P. Results of a 6-month survey of stool cultures for Escherichia coli O157:H7. Mayo Clin Proc. 1990 Jun;65(6):787–792. doi: 10.1016/s0025-6196(12)62567-1. [DOI] [PubMed] [Google Scholar]
  15. Milford D. V., Taylor C. M., Guttridge B., Hall S. M., Rowe B., Kleanthous H. Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects. Arch Dis Child. 1990 Jul;65(7):716–721. doi: 10.1136/adc.65.7.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Milford D. V., Taylor C. M. New insights into the haemolytic uraemic syndromes. Arch Dis Child. 1990 Jul;65(7):713–715. doi: 10.1136/adc.65.7.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Brien A. O., Lively T. A., Chen M. E., Rothman S. W., Formal S. B. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin. Lancet. 1983 Mar 26;1(8326 Pt 1):702–702. doi: 10.1016/s0140-6736(83)91987-6. [DOI] [PubMed] [Google Scholar]
  18. Ostroff S. M., Griffin P. M., Tauxe R. V., Shipman L. D., Greene K. D., Wells J. G., Lewis J. H., Blake P. A., Kobayashi J. M. A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol. 1990 Aug;132(2):239–247. doi: 10.1093/oxfordjournals.aje.a115653. [DOI] [PubMed] [Google Scholar]
  19. Ostroff S. M., Kobayashi J. M., Lewis J. H. Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA. 1989 Jul 21;262(3):355–359. [PubMed] [Google Scholar]
  20. Salmon R. L., Farrell I. D., Hutchison J. G., Coleman D. J., Gross R. J., Fry N. K., Rowe B., Palmer S. R. A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O 157.H7. Epidemiol Infect. 1989 Oct;103(2):249–254. doi: 10.1017/s0950268800030600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scotland S. M., Rowe B., Smith H. R., Willshaw G. A., Gross R. J. Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes. J Med Microbiol. 1988 Apr;25(4):237–243. doi: 10.1099/00222615-25-4-237. [DOI] [PubMed] [Google Scholar]
  22. Sheth K. J., Gill J. C., Leichter H. E. High-dose intravenous gamma globulin infusions in hemolytic-uremic syndrome: a preliminary report. Am J Dis Child. 1990 Mar;144(3):268–270. doi: 10.1001/archpedi.1990.02150270014009. [DOI] [PubMed] [Google Scholar]
  23. Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith H. R., Rowe B., Gross R. J., Fry N. K., Scotland S. M. Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales. Lancet. 1987 May 9;1(8541):1062–1065. doi: 10.1016/s0140-6736(87)90485-5. [DOI] [PubMed] [Google Scholar]
  25. Smith H. W., Linggood M. A. The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli. J Med Microbiol. 1971 Aug;4(3):301–305. doi: 10.1099/00222615-4-3-301. [DOI] [PubMed] [Google Scholar]
  26. Tison D. L. Culture confirmation of Escherichia coli serotype O157:H7 by direct immunofluorescence. J Clin Microbiol. 1990 Mar;28(3):612–613. doi: 10.1128/jcm.28.3.612-613.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tzipori S., Wachsmuth K. I., Smithers J., Jackson C. Studies in gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from patients with hemorrhagic colitis. Gastroenterology. 1988 Mar;94(3):590–597. doi: 10.1016/0016-5085(88)90228-4. [DOI] [PubMed] [Google Scholar]
  28. Willshaw G. A., Smith H. R., Scotland S. M., Field A. M., Rowe B. Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes. J Gen Microbiol. 1987 May;133(5):1309–1317. doi: 10.1099/00221287-133-5-1309. [DOI] [PubMed] [Google Scholar]
  29. von Wulffen H., Rüssmann H., Karch H., Meyer T., Bitzan M., Kohrt T. C., Aleksic S. Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet. 1989 Jun 24;1(8652):1449–1450. doi: 10.1016/s0140-6736(89)90151-7. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES